Delivery Order SPE2DR25D2014-SPE2DR26FZ77A
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,740.49 by the Defense Logistics Agency on September 8, 2025, with an ultimate completion date of September 29, 2025. The delivery order, identified as 4569422407, is for Proquad vials and is structured as a firm fixed price, non-set-aside contract. This award represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp was awarded a $6,683.60 delivery order by the Defense Logistics Agency (DLA) for PROQUAD vials, with performance in Conshohocken, Pennsylvania. The contract is not set-aside, was competitively awarded at firm fixed price, and carries an ultimate completion date of August 19, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a comprehensive global pharmaceutical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,271.65 by the Defense Logistics Agency on July 22, 2025, for the supply of ProQuad vials. This competitively awarded, firm fixed-price contract carries an ultimate completion date of August 12, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency valued at $1,654.33 for ProQuad vials. This competitively awarded, firm fixed-price contract has an ultimate completion date of September 5, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $16,874.40 by the Defense Logistics Agency on August 11, 2025, for the supply of ProQuad vials with an ultimate completion date of September 2, 2025. This is a firm fixed-price contract with no set-aside designation, executed through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under the company's...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency valued at $1,687.48 for ProQuad vials. This contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999 through December 2026. The award was issued on August 19, 2025, with an ultimate completion date of...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,687.48 by the Defense Logistics Agency (DLA) on September 25, 2025, for the supply of ProQuad vials with an ultimate completion date of October 17, 2025. The contract is competitively awarded with no set-aside designation and utilizes firm fixed-price pricing. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order for ProQuad vials valued at $6,683.60 by the Defense Logistics Agency (DLA). The contract, awarded on July 21, 2025, with an ultimate completion date of August 11, 2025, represents a firm fixed-price delivery order with no set-aside designation. This award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- AmerisourceBergen Drug Corp was awarded a $6,749.96 firm fixed price delivery order by the Defense Logistics Agency's Medical Supply Chain on November 8, 2025, for ProQuad vials in 10-unit quantities. The contract is a non-competitive delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The product will be delivered to AmerisourceBergen's corporate office location in...
- This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is for the delivery of PROQUAD VIALS pharmaceutical products to the U.S. government. The $1,601.99 firm fixed price Delivery Order was awarded on June 7, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, with a completion date of July 1, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FZ77ADelivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency valued at $13,271.30 with a firm fixed price structure. The contract, designated 4570096180, is for PROQUAD vials and carries an ultimate completion date of December 12, 2025. This non-competitive, non-set-aside award represents a child contract under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive vehicle for pharmaceutical and medical supply procurement to support global military healthcare programs. AmerisourceBergen's award reflects its established role as a critical federal medical vendor, supplying a wide range of pharmaceuticals, vaccines, medical devices, and specialized healthcare commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. As a major pharmaceutical distributor and healthcare solutions provider, the company has demonstrated capability to compete successfully in federal procurement and fulfill delivery orders across multiple therapeutic domains. The PROQUAD vials delivery supports DLA's mission to maintain essential medical supply chains for military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.3k | 11/20/25 |